Skip to main content
Caplight Logo









Namida Lab, Inc.

Namida Lab, Inc.

Private
Fayetteville, ArkansasHealthcare & Life Scienceshttps://namidalab.com/

Last Round

Accelerator

Jun 13, 2024

Total Funding Raised

$5.05M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Namida Lab, Inc. is a biotechnology company that develops and commercializes cancer screening and diagnostic tools utilizing protein biomarkers found in human tears.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine

Business Model

B2C

Customer Profile

Usage-Based SaaS

AI Layer

Application

Keywords

breast cancer screeningat-home diagnostic testtear-based diagnosticsproteomicsclinical laboratoryCLIA-certifiedbiomarker testingnon-invasive screeningliquid biopsyfemtechprecision medicinedirect-to-consumer diagnosticsDTC health testingbreast health assessmentclinical diagnostic services

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Namida Lab, Inc. Comparables

Compare Namida Lab, Inc. with similar companies based on industry and business-model similarity.

Namida Lab, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Syantra Inc.
77%
Teal Health
70%
Myriad Genetics
61%

Namida Lab, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorJun 13, 2024
Series ANov 12, 2023
SeedAug 4, 2021

Namida Lab, Inc. Investors

Notable investors and investment history

Namida Lab, Inc. investors
InvestorRounds
Tech4EvaAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jun 18, 2026

    Monthly visitors increased 159% MoM, reaching 2.7K.

  • Jan 1, 2026

    Monthly visitors grew 128% MoM, from 1.2K to 2.8K.

Recent news

Latest coverage and updates

  • receives_awardJun 17, 2026

    Namida Lab, Inc. received award 2026 femtech world award on Jun 8th '26.

Namida Lab, Inc. Filings

Explore SEC and related filing metadata, where available.

Namida Lab, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Namida Lab, Inc.'s valuation, stock price, and market status.

Is Namida Lab, Inc. a public or private company?

Namida Lab, Inc. is a private company.

What is the current stock price of Namida Lab, Inc.?

Namida Lab, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Namida Lab, Inc. worth (valuation)?

Valuation information for Namida Lab, Inc. is not publicly available.

Can I buy Namida Lab, Inc. stock?

Namida Lab, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Namida Lab, Inc.'s last funding round?

Namida Lab, Inc.'s most recent funding round was Accelerator on June 13, 2024.

Who are the main investors in Namida Lab, Inc.?

Key investors in Namida Lab, Inc. include Tech4Eva.

Will Namida Lab, Inc. IPO soon?

No public IPO plans have been announced for Namida Lab, Inc..

How can I track Namida Lab, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Namida Lab, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFayetteville, Arkansas
Employee Range8
Year Founded2019
Last FundingJun 13, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?